Renaissance Technologies (RenTech)'s ELTX Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 121,631 shares of Elicio Therapeutics, Inc. (ELTX) worth $1.3 M, representing 0.00% of the portfolio. First purchased in 2023-Q4, this short-term holding has been held for 6 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained this position in ELTX for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2026, adding 93,520 shares. Largest reduction occurred in Q4 2025, reducing 20,560 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Elicio Therapeutics (ELTX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Elicio Therapeutics (ELTX) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +93,520 | Add 332.68% | 121,631 | $10.69 |
| Q4 2025 | -20,560 | Reduce 42.24% | 28,111 | $7.96 |
| Q3 2025 | +48,671 | New Buy | 48,671 | $10.94 |
| Q2 2024 | -11,761 | Sold Out | 0 | $0.00 |
| Q1 2024 | -4,705 | Reduce 28.57% | 11,761 | $7.57 |
| Q4 2023 | +16,466 | New Buy | 16,466 | $8.32 |
Renaissance Technologies (RenTech)'s Elicio Therapeutics Investment FAQs
Renaissance Technologies (RenTech) first purchased Elicio Therapeutics, Inc. (ELTX) in Q4 2023, acquiring 16,466 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Elicio Therapeutics, Inc. (ELTX) for 6 quarters since Q4 2023.
Renaissance Technologies (RenTech)'s largest addition to Elicio Therapeutics, Inc. (ELTX) was in Q1 2026, adding 121,631 shares worth $1.3 M.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 121,631 shares of Elicio Therapeutics, Inc. (ELTX), valued at approximately $1.3 M.
As of the Q1 2026 filing, Elicio Therapeutics, Inc. (ELTX) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Elicio Therapeutics, Inc. (ELTX) was 121,631 shares, as reported at the end of Q1 2026.